NCT05990738
DAREONTM-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy treatment 1 recruiting NCT06077500
DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer treatment 1 recruiting NCT05879978
A Study to Test How Well Different Doses of BI 764532 in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 treatment 1 / 2 recruiting NCT05963867
A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer No drug interventions treatment 1 recruiting NCT01635400
Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer treatment 2 unknown_status NCT05490472
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04180176
Prospective Clinicogenomic Program No drug interventions other 4 completed NCT03505515
Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer No drug interventions Not Available Not Available completed NCT03227016
Study in Patients With SCLC of Veliparib in Combination With Topotecan treatment 1 unknown_status NCT05616624
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers treatment 1 / 2 recruiting NCT06131840
A Study of PF-08046050 (SGN-CEACAM5C) in Adults With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06247163
PET-guided Radiotherapy for Patients With Small Cell Lung Cancer. No drug interventions Not Available Not Available recruiting NCT06264921
A Study with NKT3447 for Adults with Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06586957
A Study with NKT3964 for Adults with Advanced/Metastatic Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06558903
Searching for Predictive Biomarkers of Efficacy in Small Cell Lung Cancer Patients Treated With Chemotherapy-immunotherapy Combination Using Imaging Mass Cytometry (HYPE) No drug interventions Not Available Not Available active_not_recruiting NCT02874664
A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer treatment 1 completed NCT02763579
A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) treatment 3 completed NCT01286987
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors treatment 1 completed NCT00423254
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. No drug interventions treatment 1 completed NCT05945745
Molecular Analysis and Treatment Options of SCLC No drug interventions Not Available Not Available recruiting NCT01540045
Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT00445198
A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies treatment 1 / 2 completed NCT06247605
A Phase IIII Study of AL8326 in Small Cell Lung Cancer No drug interventions treatment 3 recruiting NCT03568097
Immunotherapy in Combination With Chemotherapy in Small-cell Lung Cancer treatment 2 active_not_recruiting NCT03512015
A Mobile Supportive Care App for Patients With Metastatic Lung Cancer No drug interventions supportive_care Not Available unknown_status NCT01187615
Determination of Safety, Efficacy, and Pharmacokinetics of "Regorafenib" Combined With Pemetrexed and Cisplatin in Patients With Nonsquamous Non-Small Cell Lung Cancer treatment 1 terminated NCT01574300
Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network No drug interventions Not Available Not Available terminated NCT00927875
A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer treatment 1 completed NCT01441349
Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer treatment 2 unknown_status NCT01222936
LBH Phase II in Small Cell Lung Cancer (SCLC) treatment 2 completed NCT06481813
Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients No drug interventions basic_science Not Available not_yet_recruiting NCT04507919
Managed Access Program Cohort Treatment Plan CTMT212X2002I to Provide Access to Trametinib and Dabrafenib Combination Therapy for Patients With BRAF V600 Mutation-positive Advanced Non-Small Cell Lung Cancer Not Available Not Available available NCT04199741
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56 No drug interventions Not Available Not Available recruiting NCT04938817
Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Investigational Agents for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98) treatment 1 / 2 active_not_recruiting NCT01941316
Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients treatment 1 / 2 completed NCT01553916
Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain supportive_care 1 / 2 completed NCT05882058
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers No drug interventions treatment 2 recruiting NCT01977235
Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer treatment 2 unknown_status NCT06177925
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC treatment 2 recruiting NCT04173325
Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer treatment 1 terminated NCT02394548
Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer No drug interventions treatment Not Available completed NCT03662074
Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer treatment 2 terminated NCT05582031
Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers treatment 2 withdrawn NCT05419076
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain No drug interventions treatment 2 recruiting NCT06501976
An Exploratory Study of Lurbinectedin With Radiotherapy in Locally-advanced SCLC After First-line Therapy treatment 2 not_yet_recruiting NCT03532880
A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer treatment 1 active_not_recruiting NCT01722292
A Study of LY2940680 in Small Cell Lung Cancer treatment 1 / 2 terminated NCT00926640
A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers treatment 1 completed NCT02628067
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) treatment 2 recruiting NCT03850067
A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer treatment 1 completed NCT02876081
Phase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial Adenocarcinoma, Harboring Wild-type EGFR, Expressing the Neurotensin - Neurotensin Receptor Complex treatment 2 withdrawn NCT03735095
Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer treatment 1 / 2 active_not_recruiting NCT02487095
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers treatment 1 / 2 active_not_recruiting NCT02658214
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors treatment 1 completed NCT04363255
First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC treatment 2 unknown_status NCT00143455
Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer treatment 3 completed NCT00299390
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer treatment 2 terminated NCT02937402
Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung Cancer No drug interventions diagnostic Not Available terminated NCT06419179
Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC) treatment 2 not_yet_recruiting NCT02397733
Memory Preservation of Prophylactic Cranial Irradiation With Hippocampal Avoidance (PREMER-TRIAL) No drug interventions prevention Not Available completed NCT04901754
Camrelizumab Plus Apatinib as Maintenance Therapy in Extensive-stage Small-cell Lung Cancer treatment 2 unknown_status NCT01317953
Oral Green Tea Extract for Small Cell Lung Cancer No drug interventions Not Available Not Available available NCT05683977
A French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer. Not Available Not Available active_not_recruiting NCT02041845
Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer No drug interventions treatment Not Available active_not_recruiting NCT05703997
FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction treatment 2 not_yet_recruiting NCT06236997
Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer treatment 2 not_yet_recruiting NCT01450761
Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone treatment 3 completed NCT00977561
A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer treatment 2 terminated NCT04672928
A Phase Ib/III Clinical Study to Evaluate the Efficacy and Safety of IBI318 in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel in Patients With Small Cell Lung Cancer Who Have Failed First-line or Above Chemotherapies treatment 1 completed NCT03232593
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s) Not Available Not Available completed NCT04996771
Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer treatment 1 / 2 recruiting NCT03517488
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors treatment 1 completed NCT04665856
Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer treatment 3 active_not_recruiting NCT04620837
Tislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line Chemotherapy treatment 2 unknown_status NCT04358237
Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer. treatment 1 / 2 active_not_recruiting NCT02062632
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy supportive_care 2 terminated NCT03221400
PEN-866 in Patients With Advanced Solid Malignancies treatment 1 / 2 unknown_status NCT03700359
A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC treatment 2 unknown_status NCT05620342
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer No drug interventions treatment 0 recruiting NCT02161419
RONICICLIB / Placebo in Combination With Chemotherapy in Small Cell Lung Cancer treatment 2 terminated NCT05224141
Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008, KEYVIBE-008) treatment 3 active_not_recruiting NCT03092934
A Study of AK-01 (LY3295668) in Solid Tumors treatment 1 / 2 completed NCT00759824
A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide treatment 2 completed NCT05049863
Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial) treatment 1 / 2 recruiting NCT05617963
Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax treatment 2 recruiting NCT04453930
A Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy（Irinotecan Plus Platinum）and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer（SCLC） treatment 2 unknown_status NCT05450965
Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer treatment 2 active_not_recruiting NCT05265429
Biology of Young Lung Cancer Study: The YOUNG LUNG Study No drug interventions Not Available Not Available recruiting NCT03994744
Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC treatment 2 unknown_status NCT03319940
Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC) treatment 1 active_not_recruiting NCT05027867
KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer treatment 2 terminated NCT04902872
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT03849469
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors treatment 1 completed NCT03509012
Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors treatment 1 active_not_recruiting NCT06529081
Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer No drug interventions treatment 2 recruiting NCT01357395
A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer treatment 2 completed NCT03963414
A Study of Durvalumab Plus Tremelimumab With Chemotherapy in Untreated ES-SCLC treatment 1 terminated NCT04028050
A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer treatment 3 completed NCT05329623
A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants. No drug interventions treatment 1 recruiting NCT01573338
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer) treatment 1 / 2 terminated NCT01306045
Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies treatment 2 completed NCT00923884
Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer No drug interventions Not Available Not Available completed NCT04985357
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs No drug interventions Not Available Not Available not_yet_recruiting NCT04622228
Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer treatment 2 completed NCT03871205
Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer No drug interventions treatment 1 unknown_status NCT03699956
RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer treatment 3 terminated NCT04308785
A Study of Atezolizumab With or Without Tiragolumab Consolidation in Limited Stage Small Cell Lung Cancer treatment 2 terminated NCT00435578
Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma treatment 2 terminated NCT00037713
Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG No drug interventions treatment 3 completed NCT04253145
Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer. treatment 1 / 2 recruiting NCT02936323
PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers treatment 1 / 2 completed NCT00294931
Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer treatment 2 completed NCT00270166
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy treatment 3 completed NCT00265200
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer diagnostic 2 terminated NCT05566041
A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer treatment 3 recruiting NCT03083691
BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer treatment 2 completed NCT02736916
HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT00637624
N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy prevention Not Available terminated NCT00308529
Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer treatment 2 completed NCT00263731
Metabolomic Analysis of Lung Cancer No drug interventions Not Available Not Available completed NCT01284348
To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer supportive_care 2 terminated NCT05557708
A Safety Study of 212Pb-Pentixather Radioligand Therapy No drug interventions treatment 0 not_yet_recruiting NCT04314401
National Cancer Institute "Cancer Moonshot Biobank" No drug interventions Not Available Not Available recruiting NCT05304793
Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer No drug interventions supportive_care Not Available completed NCT06438588
Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial No drug interventions supportive_care Not Available recruiting NCT04701307
Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas treatment 2 active_not_recruiting NCT04155034
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer No drug interventions treatment 3 recruiting NCT04242199
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02146170
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors No drug interventions Not Available Not Available recruiting NCT02769962
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer treatment 1 / 2 recruiting NCT03554473
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers treatment 1 / 2 recruiting NCT06095505
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer treatment 2 recruiting NCT06117774
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) treatment 3 recruiting NCT06203210
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer treatment 3 recruiting NCT04951947
JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung Cancer treatment 2 recruiting NCT04768296
Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250) treatment 2 completed NCT05552846
Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy No drug interventions treatment Not Available recruiting NCT05551117
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors treatment 2 active_not_recruiting NCT05620134
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer treatment 1 / 2 recruiting NCT05703269
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy No drug interventions supportive_care Not Available recruiting NCT06211036
Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab treatment 3 recruiting NCT06449209
Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy No drug interventions treatment 2 recruiting NCT06497543
Intrathecal Pemetrexed for SCLC Patients With Refractory Brain Metastases or Leptomeninges Metastatic treatment 2 not_yet_recruiting NCT06527898
Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT05783622
Study of JANX008 in Subjects with Advanced or Metastatic Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT05903092
MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer treatment 2 recruiting NCT06064500
Tarlatamab (AMG 757) Expanded Access Protocol for Advanced Small Cell Lung Cancer Not Available Not Available available NCT06612151
A Phase III Study to Evaluate the Efficacy and Safety of YL201 in Relapsed Small Cell Lung Cancer treatment 3 not_yet_recruiting NCT06592638
A Phase 1 Dose Escalation Study of ZG006 in Patients with Small Cell Lung Cancer No drug interventions treatment 1 not_yet_recruiting NCT04450043
The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance No drug interventions supportive_care Not Available unknown_status NCT00403403
A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) treatment 2 completed NCT02963090
Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer treatment 2 terminated NCT00294190
Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer treatment 2 completed NCT06480864
Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Small Cell Lung Cancer treatment Not Available not_yet_recruiting NCT01045421
Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies treatment 1 / 2 completed NCT04490421
Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer. treatment 3 unknown_status NCT05978284
Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma No drug interventions treatment 1 / 2 recruiting NCT06483919
The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer No drug interventions Not Available Not Available active_not_recruiting NCT06255197
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers No drug interventions Not Available Not Available recruiting NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05285033
RW Effectiveness of Lurbinectedin in Extensive Stage SCLC Not Available Not Available completed NCT06160596
Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis No drug interventions Not Available Not Available recruiting NCT04742959
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors treatment 1 / 2 completed NCT04672759
A Real-world Study of Durvalumab for Lung Cancer in China Not Available Not Available recruiting NCT04610658
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC treatment 1 terminated NCT04539977
PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer treatment 2 recruiting NCT04535739
PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study No drug interventions treatment 3 unknown_status NCT04500145
Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer No drug interventions treatment 3 unknown_status NCT04152499
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies treatment 1 / 2 recruiting NCT03923270
Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer treatment 1 active_not_recruiting NCT03728361
Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer treatment 2 active_not_recruiting NCT03613597
Etoposide Plus Lobaplatin Versus Etoposide Plus Cisplatin for Patients With Limited Small-cell Lung Cancer treatment 2 unknown_status NCT05420636
Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET treatment 2 recruiting NCT03345485
Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors treatment 1 / 2 completed NCT02058056
Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLC No drug interventions treatment Not Available completed NCT01797159
Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer No drug interventions treatment Not Available completed NCT04060342
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma treatment 1 terminated NCT03389087
Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer treatment 2 unknown_status NCT02297087
Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment No drug interventions diagnostic Not Available terminated NCT02995187
Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC) treatment 2 unknown_status NCT00316433
Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer treatment 2 terminated NCT00791154
QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer treatment 1 / 2 terminated NCT05257551
Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study No drug interventions Not Available Not Available recruiting NCT04332653
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT03724253
[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) No drug interventions diagnostic 2 terminated NCT03652077
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies treatment 1 completed NCT02038647
Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC) treatment 2 completed NCT01640847
MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases treatment 2 withdrawn NCT02514447
Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy treatment 1 / 2 terminated NCT01745445
Clinical Randomized Study of Concurrent Chemo-radiotherapy vs Radiotherapy Alone to Local-advanced Small Cell Lung Cancer (SCLC) No drug interventions treatment 2 unknown_status NCT05673798
Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients No drug interventions Not Available Not Available completed NCT00178698
Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors treatment 2 unknown_status NCT03879798
DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer treatment 1 / 2 terminated NCT06462105
Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer treatment Not Available not_yet_recruiting NCT02261805
A Phase I/II Study of Ganetespib in Combination With Doxorubicin treatment 1 / 2 terminated NCT01441297
BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer treatment 2 completed NCT03780283
Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC treatment 2 unknown_status NCT01880528
Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer supportive_care 2 completed NCT03041311
Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC treatment 2 terminated NCT02605811
Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer treatment 2 unknown_status NCT03033511
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) treatment 3 terminated NCT05001971
Anlotinib Plus Penpulimab for the Treatment of Sensitive Relapsed Small-Cell Lung Cancer treatment 2 unknown_status NCT00472771
INNO-206 in Patients With Small Cell Lung Cancer (SCLC) treatment 2 withdrawn NCT01943578
Value of Physical Capacity Tests in Lung Cancer No drug interventions Not Available Not Available completed NCT01237678
A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer treatment 1 / 2 terminated NCT03881488
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies treatment 1 active_not_recruiting NCT05780307
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors treatment 1 recruiting NCT01784107
A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer treatment 1 / 2 unknown_status NCT00401609
G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients treatment 1 / 2 completed NCT00617409
To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid treatment 2 completed NCT05623956
Proteomics in Small Cell Lung Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT03406715
Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC) treatment 2 terminated NCT02542137
Abscopal Effect for Metastatic Small Cell Lung Cancer treatment 2 withdrawn NCT02551432
Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer treatment 2 completed NCT05983432
Study to Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors No drug interventions treatment 1 recruiting NCT02223052
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies treatment 1 completed NCT01631552
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer treatment 1 / 2 completed NCT02661100
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients treatment 1 / 2 withdrawn NCT02152059
A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based Chemotherapy treatment 2 withdrawn NCT01486459
A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer treatment Not Available terminated NCT02819999
A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer treatment 1 terminated NCT04730999
Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer treatment 2 completed NCT03043599
Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer treatment 1 / 2 completed NCT00969306
Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients treatment 1 terminated NCT04012606
Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer No drug interventions treatment 3 unknown_status NCT02247349
BMS-986012 in Relapsed/Refractory SCLC treatment 1 / 2 completed NCT02273336
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer No drug interventions Not Available Not Available completed NCT03734913
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT00119613
A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa treatment 3 completed NCT04504513
Expanded Access to Trilaciclib for Patients Receiving Chemotherapy for Small Cell Lung Cancer Not Available Not Available approved_for_marketing NCT04352413
A Study of PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy No drug interventions treatment 2 terminated NCT01266018
Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer treatment 2 terminated NCT03651219
Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer treatment 3 unknown_status NCT06283719
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer No drug interventions treatment 1 / 2 not_yet_recruiting NCT03904719
CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC) treatment 2 unknown_status NCT02593019
Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients treatment 2 completed NCT06505824
A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors No drug interventions treatment 1 recruiting NCT01872416
A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT02324296
PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases Not Available Not Available completed NCT01173458
Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC) No drug interventions Not Available Not Available completed NCT05337163
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China No drug interventions Not Available Not Available completed NCT00415363
Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy treatment 2 completed NCT04171986
Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis prevention Not Available unknown_status NCT00958022
Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer treatment 1 terminated NCT04165330
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors treatment 1 / 2 active_not_recruiting NCT05882630
Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer treatment 1 / 2 not_yet_recruiting NCT02875457
Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin treatment 3 unknown_status NCT00475657
Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer treatment 2 terminated NCT00755157
Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer treatment 2 withdrawn NCT06486428
Small Cell Lung Cancer Community Engagement to Eliminate Research Disparities No drug interventions Not Available Not Available not_yet_recruiting NCT06457906
SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC No drug interventions treatment 3 recruiting NCT06424067
Phase 2 Study of Fingolimod in Lung Cancers treatment 2 not_yet_recruiting NCT05957510
Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment treatment 2 recruiting NCT05829057
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 No drug interventions treatment 1 recruiting NCT05800587
Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer treatment 2 recruiting NCT05761977
Durvalumab in Combination With Standard Chemotherapy of Patients With Extensive Stage Small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT05354700
A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer treatment 2 unknown_status NCT05068232
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES) treatment 2 recruiting NCT04923776
Liver Directed RT + Chemo-immunotherapy for ES-SCLC treatment 2 recruiting NCT04790955
Effect of Combination Therapy on SCLC After Initial Treatment Failure No drug interventions Not Available Not Available unknown_status NCT04740021
Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer treatment 2 unknown_status NCT04745689
Study of AZD2811 + Durvalumab in ES-SCLC treatment 2 active_not_recruiting NCT04596033
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy treatment 1 terminated NCT04610684
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases treatment 2 terminated NCT04510129
A Multicenter Cancer Biospecimen Collection Study No drug interventions Not Available Not Available recruiting NCT04187872
LITT and Pembrolizumab in Recurrent Brain Metastasis treatment 1 terminated NCT04170946
Talazoparib and Thoracic RT for ES-SCLC No drug interventions treatment 1 recruiting NCT04168281
Watchful Observation of Patients With LD-SCLC Instead of the PCI No drug interventions other Not Available unknown_status NCT04116320
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors treatment 1 active_not_recruiting NCT04010357
Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC treatment 2 recruiting NCT04683198
Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC treatment 2 unknown_status NCT03583528
DOTATOC PET/CT for Imaging NET Patients No drug interventions Not Available Not Available recruiting NCT03613753
Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer treatment 2 unknown_status NCT03514849
Clinical Study of Combined Radical Operation With Postoperative Adjuvant Chemotherapy and Prophylactic Cranial Irradiation in pT1-2N0M0 Stage of Small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT04951115
A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer treatment 2 completed NCT04834778
A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD) No drug interventions treatment 1 completed NCT05578326
Study of Trilaciclib and Lurbinectidin treatment 2 recruiting NCT05411679
EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer treatment 2 withdrawn NCT05091567
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer treatment 3 active_not_recruiting NCT05223647
Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer treatment 3 recruiting NCT05253053
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT04324437
eRAPID: Online Symptom Reporting in Lung Cancer No drug interventions other Not Available completed NCT03371979
Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer treatment 1 / 2 completed NCT03239171
Bioinformation Therapy for Lung Cancer No drug interventions treatment 2 / 3 completed NCT02566993
Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer treatment 3 completed NCT00466466
Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients treatment 1 completed NCT04022876
A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection) treatment 1 terminated NCT04579757
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT06295926
Serplulimab Combined With CCRT for LS-SCLC. treatment 2 recruiting NCT04140526
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC treatment 1 / 2 recruiting NCT01429766
A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients No drug interventions supportive_care 2 unknown_status NCT01064466
Pharmacogenomics IND EXEMPT SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms health_services_research 2 / 3 active_not_recruiting NCT00812266
Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED) treatment 3 terminated NCT01500720
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer treatment 2 completed NCT04192682
Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer treatment 2 / 3 unknown_status NCT03009682
Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A Mutations treatment 2 completed NCT00765973
Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors treatment 1 completed NCT01497873
A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer treatment 2 completed NCT02577627
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC No drug interventions Not Available Not Available unknown_status NCT00043927
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults treatment 3 completed NCT00697476
Study of Oral Vorinostat in Combination With Topotecan in Patients With Chemosensitive Recurrent SCLC treatment 1 / 2 terminated NCT05572476
Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer treatment 2 withdrawn NCT06406660
Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT04451460
Effect of Hyponatremia in Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT00388960
Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer treatment 2 completed NCT03467360
Inhibition of CArbonic Anhydrase in Combination With Platinum and Etoposide-based Radiochemotherapy in Patients With Localized Small Cell Lung Cancer treatment 1 recruiting NCT00930891
Bevacizumab in Extensive Small Cell Lung Cancer treatment 2 / 3 completed NCT03365791
PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies treatment 2 completed NCT03898791
A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer treatment 1 completed NCT00465491
Study of Picoplatin Efficacy After Relapse treatment 3 unknown_status NCT03219762
Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLC health_services_research 2 unknown_status NCT00702962
Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer treatment 1 / 2 terminated NCT00043862
The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) treatment 2 completed NCT02391480
A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer treatment 1 completed NCT02735980
A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer treatment 2 completed NCT06581380
JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer treatment 3 not_yet_recruiting NCT00065429
Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer treatment 1 / 2 completed NCT02995889
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer No drug interventions diagnostic Not Available completed NCT00349492
A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer treatment 3 completed NCT00695292
Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer treatment 2 completed NCT02815592
Trial of BMS-986012 in Combination With Platinum and Etoposide treatment 1 completed NCT00912392
Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) treatment 2 completed NCT00374140
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer treatment 2 completed NCT03228667
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors treatment 2 active_not_recruiting NCT00132704
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation No drug interventions Not Available Not Available completed NCT05769504
Examining Clinical Trial Participation for Small Cell Lung Cancer Patients No drug interventions Not Available Not Available not_yet_recruiting NCT02250404
Molecular Signatures of Relapse in Tissue Samples From Patients With Small Cell Lung Cancer Who Are Receiving Cisplatin and Etoposide No drug interventions Not Available Not Available withdrawn NCT03076372
A Study Evaluating MM-310 in Patients With Solid Tumors No drug interventions treatment 1 unknown_status NCT02425072
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer No drug interventions treatment 2 withdrawn NCT02105168
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment No drug interventions screening Not Available unknown_status NCT00916669
A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) treatment 2 withdrawn NCT04504669
First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours treatment 1 active_not_recruiting NCT00319969
Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy. treatment 2 completed NCT05889546
Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT02738346
SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013 treatment 3 unknown_status NCT06364046
Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC treatment Not Available not_yet_recruiting NCT01040312
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors Not Available Not Available completed NCT03061812
Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE) treatment 3 completed NCT04870112
A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer treatment 1 terminated NCT02349412
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers No drug interventions supportive_care 3 completed NCT02337712
Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer treatment 2 unknown_status NCT04920981
Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC No drug interventions Not Available Not Available completed NCT02200081
Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC No drug interventions treatment 2 completed NCT04079595
Closed vs. Open Face Masks for Cranial Radiotherapy No drug interventions other Not Available completed NCT02949895
Study of BMS-986012 in Subjects With Small Cell Lung Caner treatment 1 completed NCT04890795
A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer No drug interventions treatment 1 / 2 unknown_status NCT04209595
PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers treatment 1 / 2 active_not_recruiting NCT03890055
Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride treatment 4 unknown_status NCT03913455
Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer treatment 2 completed NCT04073550
Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer treatment 3 unknown_status NCT02738723
SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC No drug interventions treatment 2 unknown_status NCT00717938
A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer treatment 3 completed NCT00418743
Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC) No drug interventions Not Available Not Available unknown_status NCT02913443
A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC) No drug interventions treatment 1 completed NCT05296603
Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer treatment 2 recruiting NCT03503890
Expanded Access to Rovalpituzumab Tesirine Not Available Not Available no_longer_available NCT02289690
Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer treatment 1 / 2 completed NCT03392064
A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC treatment 1 suspended NCT06257264
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors treatment 1 recruiting NCT00447421
A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy treatment 1 / 2 terminated NCT04256421
A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer treatment 3 active_not_recruiting NCT02995902
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer No drug interventions diagnostic Not Available completed NCT00531284
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma treatment 1 / 2 completed NCT01025284
A Study for Participants With Small-Cell Lung Cancer treatment 2 completed NCT02906384
Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC) No drug interventions treatment 2 unknown_status NCT06498479
ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer treatment 3 not_yet_recruiting NCT01840579
Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011) treatment 1 completed NCT06047379
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis treatment 1 / 2 recruiting NCT03334487
Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer treatment 3 withdrawn NCT04553133
PF-07104091 as a Single Agent and in Combination Therapy treatment 1 / 2 active_not_recruiting NCT02046733
Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease treatment 2 unknown_status NCT02331251
Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) treatment 1 / 2 terminated NCT00547651
AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy treatment 3 completed NCT01069653
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer No drug interventions treatment 1 completed NCT00290953
Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide treatment 2 / 3 completed NCT03958045
Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma treatment 2 active_not_recruiting NCT04885998
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC) treatment 1 active_not_recruiting NCT03752398
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) treatment 1 completed NCT00213798
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients No drug interventions screening Not Available completed NCT03585998
Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer treatment 2 unknown_status NCT03162705
Molecular Profiling in Small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT03703297
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy treatment 3 active_not_recruiting NCT03059797
Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202) treatment 2 completed NCT04314297
Anlotinib In Combination With Durvalumab As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study treatment 2 unknown_status NCT02262897
The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer treatment 2 unknown_status NCT04041011
A Study of SHR-1316 and Fluzoparib（SHR-3162） in Small Cell Lung Cancer Patients treatment 1 completed NCT03080311
A Study of APG-1252 in Patients With SCLC or Other Solid Tumors treatment 1 completed NCT00397293
Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer treatment 1 / 2 completed NCT05797493
Panomic Approach to Immune-Connected Assays in Small Cell Lung Cancer Not Available Not Available recruiting NCT00375193
Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy treatment 2 completed NCT03116971
Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED) treatment 1 terminated NCT03093688
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor No drug interventions treatment 1 / 2 unknown_status NCT00298688
A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer treatment 2 completed NCT04400188
A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer treatment 1 / 2 active_not_recruiting NCT02688907
Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 Mutation treatment 2 terminated NCT01401907
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies No drug interventions supportive_care Not Available completed NCT03782207
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice Not Available Not Available active_not_recruiting NCT00483509
Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma treatment 2 completed NCT02980809
Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer treatment 2 unknown_status NCT04731909
Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer treatment Not Available unknown_status NCT03670056
Ipilimumab and Nivolumab in Recurrent Extensive Stage Small Cell Lung Cancer After Receiving Platinum-based Chemotherapy treatment 2 active_not_recruiting NCT01809756
The Effect of Caphosol® on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/Radiotherapy No drug interventions prevention Not Available terminated NCT00686985
Docetaxel - Carboplatin as Second Line Treatment in Patients With Small Cell Lung Cancer treatment 2 unknown_status NCT00080015
Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC) treatment 2 completed NCT00363415
Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer treatment 3 completed NCT04291937
A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA Not Available Not Available approved_for_marketing NCT04210037
Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer treatment 1 / 2 terminated NCT00455052
A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors treatment 1 completed NCT02367352
Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors treatment 1 terminated NCT02945852
Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy. treatment 2 completed NCT01392352
HYPAZ: Hypertension Induced by Pazopanib basic_science 2 terminated NCT04128800
Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer treatment 2 unknown_status NCT00317200
A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer treatment 2 completed NCT03983759
Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer treatment 2 unknown_status NCT01221675
TF2- Small Cell Lung Cancer Radio Immunotherapy No drug interventions treatment 1 / 2 completed NCT01780675
Hippocampus Avoidance PCI vs PCI No drug interventions treatment 3 completed NCT03366675
AZD 2811 Monotherapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N3] No drug interventions treatment 2 terminated NCT05886075
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT02499770
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) treatment 1 / 2 completed NCT05371899
Mass Balance Study of [14C]Chiauranib treatment Not Available completed NCT01487499
Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC) treatment 3 terminated NCT01881906
Exercise in Advanced Stage Lung Cancer Patients No drug interventions supportive_care Not Available completed NCT01417806
Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer treatment 2 unknown_status NCT04472949
Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). treatment 2 active_not_recruiting NCT05191849
Circulating EV Long RNA Profiles in SCLC No drug interventions diagnostic Not Available recruiting NCT03088813
Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer treatment 3 completed NCT04830813
Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer treatment 3 recruiting NCT00951613
A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer treatment 2 completed NCT06514118
Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT06103682
LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE) No drug interventions treatment Not Available recruiting NCT06022757
Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19) treatment 1 / 2 recruiting NCT05636618
Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors No drug interventions treatment 1 / 2 recruiting NCT04706962
TH1902 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04542369
Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung Cancer treatment 2 recruiting NCT04471727
A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001) treatment 1 / 2 recruiting NCT04234113
Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors treatment 1 active_not_recruiting NCT04247126
A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors treatment 1 completed NCT04106167
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy No drug interventions Not Available Not Available terminated NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) No drug interventions Not Available Not Available unknown_status NCT03761914
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers treatment 1 / 2 active_not_recruiting NCT04691063
The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC. treatment 3 enrolling_by_invitation NCT03583086
Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors treatment 1 / 2 active_not_recruiting NCT03540420
Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer treatment 2 active_not_recruiting NCT03547804
A Prospective, Single-center, One-arm Clinical Study of Apatinib Combined With Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer treatment 2 completed NCT03523234
Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage No drug interventions treatment Not Available unknown_status NCT04342429
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT04640480
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors treatment 1 not_yet_recruiting NCT04696939
Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients treatment 2 unknown_status NCT05254119
DIAGNOSIS, TREATMENT AND OUTCOME OF LUNG CANCER PATIENTS No drug interventions Not Available Not Available active_not_recruiting NCT03417895
SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy treatment 2 completed NCT03219268
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms treatment 1 completed NCT02622581
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients No drug interventions Not Available Not Available recruiting NCT02688673
DC Vaccine Combined With CIK Cells in Patients With SCLC No drug interventions treatment 1 / 2 unknown_status NCT00286169
Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC) treatment 3 terminated NCT00144989
A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC treatment 3 completed NCT04272034
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02039518
Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients treatment 2 unknown_status NCT05731518
SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC) treatment 1 / 2 recruiting NCT05924841
A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung Cancer No drug interventions treatment 2 recruiting NCT01426841
Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer No drug interventions treatment 1 unknown_status NCT04698941
Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy treatment 2 unknown_status NCT01752517
Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer Not Available Not Available unknown_status NCT00452634
Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) treatment 2 completed NCT00454324
Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer treatment 2 terminated NCT03297424
A Study of PLX2853 in Advanced Malignancies. No drug interventions treatment 1 completed NCT02109016
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations treatment 2 terminated NCT00216216
Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer treatment 2 terminated NCT04005716
Study of Platinum Plus Etoposide With or Without BGB-A317 in Participants With Untreated Extensive-Stage Small Cell Lung Cancer treatment 3 completed NCT01421316
Hair-sparing Whole Brain Radiotherapy No drug interventions treatment 2 terminated NCT03325816
Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer treatment 1 / 2 completed NCT00298896
Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer treatment 2 completed NCT00168896
A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage treatment 2 / 3 unknown_status NCT00526396
STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study treatment 3 active_not_recruiting NCT01165658
Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies No drug interventions treatment 1 terminated NCT00527735
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) treatment 2 completed NCT05337735
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers treatment 2 suspended NCT03419286
Transformation Into Small Cell Lung Cancer : a Mode of Resistance to Treatment No drug interventions Not Available Not Available completed NCT00156286
Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC treatment 2 completed NCT06467786
Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer treatment 4 recruiting NCT00921739
Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies No drug interventions treatment 1 completed NCT03086239
A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung Cancer treatment 1 completed NCT01592422
Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT04361825
Durvalumab(MEDI4736) and AZD6738 Combination Therapy in Relapsed Small Cell Lung Cancer Subjects treatment 2 completed NCT02171325
Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment treatment 2 unknown_status NCT00546130
Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer treatment 2 unknown_status NCT03098030
Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer treatment 2 / 3 completed NCT00856830
Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer treatment 1 / 2 completed NCT06500026
A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer treatment 3 recruiting NCT00494026
Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC) treatment 2 terminated NCT00613626
Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer treatment 2 completed NCT03026166
A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer treatment 1 / 2 terminated NCT05429866
Immunological Variables Associated to ICI Toxicity in Cancer Patients other 2 recruiting NCT04434482
IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer treatment 1 / 2 recruiting NCT01575782
Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer treatment 1 terminated NCT02649673
LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies treatment 1 terminated NCT01159327
Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy treatment 2 terminated NCT04802876
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors treatment 2 recruiting NCT05628376
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO No drug interventions Not Available Not Available recruiting NCT03639194
A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer treatment 1 completed NCT05245994
An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese treatment 2 unknown_status NCT03391362
Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases No drug interventions treatment Not Available active_not_recruiting NCT05363280
Phase 2 Safety and Efficacy Evaluation of AL8326 in ≥2nd Line SCLC No drug interventions treatment 2 recruiting NCT04952480
Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer No drug interventions treatment 2 recruiting NCT03741829
TS Overexpression in SCLC: Mechanism and Therapeutic Targeting No drug interventions Not Available Not Available completed NCT04501029
A Study of Gimatecan (ST1481) in Small Cell Lung Cancer treatment 2 unknown_status NCT00252889
Doxil Topotecan Doublet Cancer Study treatment 1 completed NCT05595889
Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer treatment 2 not_yet_recruiting NCT04782089
Study of PD-1 Antibody and PARP Inhibitor in Extensive Stage Small Cell Lung Cancer treatment Not Available unknown_status NCT01831089
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors treatment 1 completed NCT05271292
Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. treatment 1 / 2 recruiting NCT05619744
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas treatment 1 recruiting NCT03059667
Immunotherapy as Second-line in Patient With Small Cell Lung Cancer treatment 2 completed NCT04924101
Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99) treatment 2 active_not_recruiting NCT04985201
Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy treatment 2 unknown_status NCT03776604
PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy No drug interventions prevention Not Available unknown_status NCT04624204
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013) treatment 3 active_not_recruiting NCT04032704
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors treatment 2 terminated NCT02446704
Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy treatment 1 / 2 unknown_status NCT02978404
Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases treatment 2 completed NCT05563272
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors diagnostic 2 recruiting NCT03488472
Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain No drug interventions treatment Not Available terminated NCT01242072
Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies No drug interventions treatment 1 unknown_status NCT03997968
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT02674568
Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer treatment 2 completed NCT03410368
NK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer. treatment 2 unknown_status NCT02722369
STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC) treatment 2 terminated NCT01253369
Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer treatment 2 completed NCT01591512
A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer No drug interventions Not Available Not Available terminated NCT00116610
Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer treatment 2 completed NCT04422210
A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC). treatment 1 terminated NCT03841110
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors treatment 1 completed NCT04381910
Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer treatment 2 completed NCT04590781
Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer treatment 1 / 2 terminated NCT01079481
Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer treatment 1 completed NCT00883181
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy No drug interventions Not Available Not Available completed NCT01125995
Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer No drug interventions treatment 3 completed NCT00776295
Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer No drug interventions treatment 2 terminated NCT02500914
SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma No drug interventions treatment 1 terminated NCT01182155
Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation No drug interventions Not Available Not Available completed NCT03106155
Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR Amplification treatment 2 terminated NCT02348450
Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer treatment 4 unknown_status NCT00572923
Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-Scans No drug interventions Not Available Not Available completed NCT01173523
Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer treatment 2 completed NCT04841538
A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic Tumors No drug interventions treatment 1 / 2 withdrawn NCT03216343
Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer treatment 1 completed NCT06228326
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs No drug interventions treatment 1 recruiting NCT00997061
SCOT Registry: Small Cell Lung Cancer Treatment and Outcome Not Available Not Available completed NCT00046111
A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors treatment 1 completed NCT03499678
Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA No drug interventions Not Available Not Available terminated NCT04440800
Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment No drug interventions Not Available Not Available unknown_status NCT00698516
Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer treatment 2 completed NCT01313663
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population treatment 2 terminated NCT00316186
First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin treatment 2 completed NCT00276276
Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer treatment 3 completed NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors treatment 1 active_not_recruiting NCT01037023
Regulatory Hycamtin(Oral) PMS Not Available Not Available completed NCT06293833
Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan No drug interventions screening Not Available enrolling_by_invitation NCT00320359
Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer treatment 3 completed NCT04986670
NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT05228496
A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC treatment 2 active_not_recruiting NCT05320458
Pulmonary Rehabılıtatıon Wıth Non-Small Lung Cancer No drug interventions treatment Not Available unknown_status NCT00259935
A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors treatment 1 completed NCT04314895
Trial of NanoPac Intratumoral Injection in Lung Cancer treatment 2 completed NCT01071434
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors No drug interventions Not Available Not Available terminated NCT01188486
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer device_feasibility Not Available terminated NCT01137162
Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors No drug interventions Not Available Not Available terminated NCT02030184
Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas treatment 1 / 2 withdrawn NCT04727853
Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC) treatment 2 completed NCT01719861
Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors treatment 2 terminated NCT03538028
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies treatment 1 completed NCT03066778
A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) treatment 3 completed NCT05652686
A Study of PT217 in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) treatment 1 / 2 recruiting NCT01210131
Hypoxia-guided Radiotherapy With Cisplatin-etoposide in Stage I-III : Small Cell Lung Cancer(SCLC) No drug interventions treatment Not Available withdrawn NCT05158491
Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLC treatment 1 / 2 unknown_status NCT06485544
Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial treatment 2 recruiting NCT02934503
Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) treatment 2 terminated NCT01904253
A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy treatment 2 terminated NCT03460977
Mevrometostat Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma treatment 1 recruiting NCT03708328
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors treatment 1 completed NCT02769832
Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer treatment 2 active_not_recruiting NCT03811652
A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT05027100
Tislelizumab Combined With Anlotinib and 2-cycles Irinotecan as Second Line Treatment of SCLC treatment Not Available unknown_status NCT02748889
Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer treatment 1 / 2 terminated NCT02069158
Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor treatment 1 completed NCT05740566
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer treatment 3 active_not_recruiting NCT04285866
Spanish Real World Data on Patients Treated With Durvalumab After Chemoradiotherapy. Not Available Not Available completed NCT02580994
Pembrolizumab in Untreated Extensive SCLC treatment 2 completed NCT02715102
Circulating Tumor DNA in Patients at High Risk for Lung Cancer No drug interventions Not Available Not Available terminated NCT00580320
Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma treatment 1 completed NCT04802174
Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers treatment 1 / 2 recruiting NCT04826341
A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors treatment 1 / 2 recruiting NCT05130255
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 No drug interventions treatment 1 recruiting NCT05546268
Study of Oral MRT-2359 in Selected Cancer Patients treatment 1 / 2 recruiting NCT05655598
TAS-116 Plus Palbociclib in Breast and Rb-null Cancer treatment 1 withdrawn NCT06021483
Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection No drug interventions Not Available Not Available recruiting NCT06179069
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer treatment 1 recruiting NCT06616532
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer treatment 3 not_yet_recruiting NCT04677361
Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab treatment 0 withdrawn NCT05026593
A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer treatment 1 completed NCT00346385
BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors treatment 1 completed NCT02611024
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors treatment 1 / 2 recruiting NCT01713296
Pazopanib in Relapsed and Refractory Small Cell Lung Cancer treatment 2 completed NCT01797874
Pazopanib Maintenance for SCLC treatment 2 completed NCT06441344
Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell treatment 3 not_yet_recruiting NCT02734004
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. treatment 1 / 2 active_not_recruiting NCT05879068
A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC treatment 2 recruiting NCT05844150
A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC treatment 2 / 3 recruiting NCT00046787
Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer treatment 2 completed NCT03575793
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer treatment 1 / 2 active_not_recruiting NCT01829971
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection No drug interventions treatment 1 terminated NCT03297788
Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases No drug interventions treatment Not Available completed NCT03428607
Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2] treatment 2 completed NCT06475209
Adebrelimab + Apatinib in SCLC Maintenance Therapy treatment 2 recruiting NCT06116019
Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS) No drug interventions Not Available Not Available recruiting NCT04684017
Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer treatment 2 unknown_status NCT00522639
Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation No drug interventions diagnostic 3 terminated NCT04750239
Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer treatment 1 / 2 terminated NCT04686682
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors No drug interventions treatment 1 / 2 recruiting NCT06534762
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study treatment 2 recruiting NCT02990780
Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC No drug interventions treatment 3 unknown_status NCT03244904
Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment No drug interventions Not Available Not Available unknown_status NCT06479811
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers treatment 1 not_yet_recruiting NCT02688894
The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S] No drug interventions Not Available Not Available recruiting